CV Sciences, Inc. (CVSI) financial statements (2020 and earlier)

Company profile

Business Address 10070 BARNES CANYON ROAD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments141321122
Cash and cash equivalents141321122
Restricted cash and investments1      
Receivables4320121
Inventory, net of allowances, customer advances and progress billings1073314122
Inventory1073314122
Prepaid expense 211010
Other current assets  0    
Other undisclosed current assets8000 12
Total current assets:36258517178
Noncurrent Assets
Inventory, Noncurrent 166   
Property, plant and equipment3320010
Long-term investments and receivables   0 00
Accounts and financing receivable, after allowance for credit loss   0 00
Intangible assets, net (including goodwill)77771045
Goodwill3333522
Intangible assets, net (excluding goodwill)4444633
Other noncurrent assets1      
Deferred tax assets, net    21
Other undisclosed noncurrent assets910  (2)(1)
Total noncurrent assets:201115141156
TOTAL ASSETS:57372319272214
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11431110
Accounts payable1111110
Accrued liabilities10320100
Employee-related liabilities     0 
Debt 0121  
Derivative instruments and hedges, liabilities   0   
Business combination, contingent consideration, liability    0 
Other undisclosed current liabilities1    (0)0
Total current liabilities:12433210
Noncurrent Liabilities
Long-term debt and lease obligation  11   
Long-term debt, excluding current maturities  11   
Liabilities, other than long-term debt11222  
Deferred revenue and credits1    
Contract with customer, liability1
Deferred tax liabilities, net1 122  
Other liabilities0      
Other undisclosed noncurrent liabilities101    6
Total noncurrent liabilities:112322 6
Total liabilities:23765416
Stockholders' equity
Stockholders' equity attributable to parent3330161323218
Common stock0000000
Additional paid in capital68555143392511
Accumulated deficit(35)(25)(35)(30)(16)(4)(2)
Total stockholders' equity:3330161323218
TOTAL LIABILITIES AND EQUITY:57372319272214

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues5948211112102
Revenue, net0 552
Financial services revenue   8 
Cost of revenue(18)(14)(6)(4)(4)(4)(1)
Cost of goods and services sold  (1)(4)(0)(0) 
Gross profit:4034147761
Operating expenses(64)(24)(19)(14)(19)(14)(3)
Other operating income (expense), net
(Other Expenses)
     (0)1
Other undisclosed operating income (loss)17  (6)10(1)
Operating income (loss):(7)10(5)(13)(11)(9)(2)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(0)(0)(1)(1)(1)7 
Interest and debt expense(0)(0)(0)(1)(1)(1)(0)
Income (loss) from continuing operations before equity method investments, income taxes:(7)10(6)(15)(13)(2)(2)
Loss from equity method investments     (0)(0)
Other undisclosed income from continuing operations before income taxes0001   
Income (loss) from continuing operations before income taxes:(7)10(5)(14)(13)(2)(2)
Income tax expense (benefit)0(0)0    
Income (loss) before gain (loss) on sale of properties:(7)10(5)(14)(13)(2)(2)
Other undisclosed net income    11 
Net income (loss) available to common stockholders, diluted:(7)10(5)(14)(12)(1)(2)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(7)10(5)(14)(12)(1)(2)
Comprehensive income (loss), net of tax, attributable to parent:(7)10(5)(14)(12)(1)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: